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ABSTRACT 
Average length of inpatient hospital stays are a concern of many 
stakeholders within the mental health care community, mental health providers, 
clinics, hospitals, and insurance companies. An analysis was conducted to 
determine whether average length of stay is significantly related to readmission 
rates at industry standard levels of 7 day readmission and 30 day readmission. The 
results showed that the shortest stay group of 2-3 days and the longest stay group of 
8+ days had significantly higher rates of readmission both at 7 day and 30 day 
readmissions. Further research is necessary to determine both the reliability of 
these results, and causal explanations. 
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Chapter I: Introduction 
Average length of stay and readmission rates are a common concern of healthcare 
providers, mental healthcare providers, and insurance companies alike. The length of an 
inpatient's hospital stay may predict whether they will consequently return to a normal 
life or be readmitted to another inpatient stay. The length of an inpatient hospital stay is 
expensive for everyone involved, but it is also a critical variable in the effective treatment 
of many psychiatric illnesses. Therefore, it may partially determine the likelihood of 
readmission of the patient into inpatient care at a later time. 
The determination of how long a patient should be in the hospital for psychiatric 
treatment is not an easy decision for anyone involved. There are many factors which 
affect the length of stay ranging from diagnosis, co-morbidity of medical illnesses, and 
age of the patient. Additional contributing factors include previous success of the 
particular inpatient program related to the particular case at hand, availability of effective 
outpatient treatment options, availability of effective partial hospitalization options, and 
so forth. The intention of the present research is the initiation of a series of studies to 
delineate and thoroughly describe length of stay, readmission, and its implications to the 
field. 
Statement ofthe Problem 
Differing lengths of hospital stay are differentially effective at reducing the 
readmission rate. The intent of this research is to examine what length of stay serves the 
psychiatric patient best in regards to avoidance of readmission to inpatient care. 
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Purpose ofthe Study 
The purpose of this study was to examine variances between different groupings 
of average length of stay and readmission rates at 7 days and 30 days. Readmission rates 
at 7 days and 30 days post discharge are considered a facility standard for quality care. 
Assumptions ofthe Study 
It is assumed that the membership ofthe mental health insurance company is 
similar to the overall mental health patient population. Industry standard of care related to 
readmission rates at 7 days and 30 days are assumed to be valid measures for quality of 
care. 
Definition ofTerms 
Average length of stay is defined as the length of stay that is typical for an 
inpatient hospital stay. 
Readmission is defined as the re-admittance of an inpatient mental health patient 
to another inpatient mental health stay. 
Readmission at 7 days is defined as re-admittance within 7 days of discharge from 
an inpatient mental health stay. 
Readmission at 30 days is defined as re-admittance within 30 days of discharge 
from an inpatient mental health stay, not including those counted as re-admitted within 7 
days of discharge. 
Days paid is assumed equivalent to length of stay, as the length of stay and the 
days paid are essentially the same. 
Partial hospitalization is defined as a patient commuting to the hospital up to 7 
days a week for treatment but residing at home. 
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Methodology 
The population consisted of all members of the mental health insurance company 
who had claims paid between July 1,2003 to June 30, 2005 and January 1,2005 to 
December 31, 2006, including children, adolescents, adults, geriatric, eating disorders, 
complex cases, and substance abuse and detoxification inpatients. No claims were 
excluded from the analysis. 
Diagnostic population types for Eating Disorders, Complex Cases, and Alcohol & 
Substance Abuse were separated based upon the primary and secondary diagnosis code 
on the claim. If the claim did not fit into one of those three diagnostic populations, then 
the claim was assigned to Adult General Mental Health Diagnostic Population if the age 
of the patient was 18 years or older, and Child General Mental Health Diagnostic 
Population if the age of the patient was under 18 years. 
A thorough literature review was conducted before data analysis was begun in 
order to ensure a comprehensive understanding of the problem. After the literature review 
was complete the data set was formatted and analyzed using SAS Version 9.1. 
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Chapter II: Literature Review 
According to Lieberman, Wiitala, Elliott, McCormick, & Goyette (1998), 
The past decade has seen dramatic changes in the role played by 
psychiatric hospitals in the care of patients. Patients who would have 
remained hospitalized for weeks, months, or even years are now treated 
mostly or entirely in outpatient settings. Lengths of stay are measured in 
days. Goals of admission have also changed greatly, from furthering 
development and building psychological "structure" to stabilizing 
symptoms, adjusting medication, and facilitating connections to outpatient 
care. (p.905) 
Lieberman, et aI., (1998) conducted a study at Dartmouth-Hitchcock Medical Center in 
New Hampshire while the program went through a change from longer lengths of stay in 
1988 to shorter lengths of stay up to approximately 1996. The study consisted of three 
cohorts during this time frame. They were grouped as follows: cohort 1, 1988-1991; 
cohort 2, 1992-1993; and cohort 3,1995-1996. It was discovered that the final cohort 3, 
consisting of patients with the shortest hospital stay, showed no significant difference in 
levels of functioning between those in earlier cohort 1 who were solely hospitalized 
versus those in cohort 2 who were hospitalized and then followed up with partial 
hospitalization. This finding could be due to the differences in overall level of illness 
between the two subgroups, further investigation is needed. 
Another finding was that the length of stay for those not experiencing a partial 
hospitalization was approximately 9.6 days, in contrast to those experiencing a partial 
hospitalization, whose length of stay averaged 6.7 days, followed by weeks ofpartial 
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hospitalization. Additionally, readmission rates from cohort 1,N=12 (17.6%) to cohort 2, 
N=2 (6.3%) decreased, but they increased from cohort 2, N=2 (6.3%) to cohort 3, N=12 
(17.1%). Although, there seemed to be no change in readmission rates in relation to the 
reduction in the average length of stay, there did appear to be adverse affects suffered by 
the patient population as shown through the study. These adverse affects are indicated by 
Liberman, et al., (1998) as he concluded "patients are now more depressed and more 
globally impaired when they leave the hospital." (p.908) 
According to the work of Liberman, et al., (1998), 
... as clinical experience suggests, depressed patients are now discharged more 
depressed than they previously were, and with lower scores on the Global Assessment 
of Functioning Scale. One month after discharge, although readmission rates were 
equal, global and work functioning remained lower among the short-stay group. 
(p.908) 
The findings of Liberman, et al., (1998) should not only be of concern to 
researchers and clinicians, but to patients, counselors, and insurance companies. This 
seems to be a time when we are all considering the rising levels of stress within our 
culture and the rising cost of healthcare. An individual deserves the care that best treats 
their illness so that they can return to their lives and their work functioning at levels that 
are as high as possible. Outpatient care may appear to be cheaper, but the length ofthe 
care may be more costly and more stressful than inpatient care. In this study this seems to 
be the case as indicated by longer rather than shorter hospital stays or partial 
hospitalization. 
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An analysis completed by Case, Olfson, Marcus, and Siegel (2007) on children 
and adolescents in community based hospitals indicated by ICD-9-CM codes 290 to 319 
showed no significant changes in discharge rates in the decade of 1990 to 2000. In 
addition, "The proportion of discharges diagnosed with principal bipolar disorders rose 
dramatically from 2.9% to 15.21%. Increases were also observed in the proportion 
diagnosed with psychotic disorders" (p.92). Despite the decrease in length of stay and the 
increase in severity of illness in this particular population, it appears that clinicians are 
doing more in a shorter amount of time. "Inpatient clinicians who on average evaluated, 
treated, and discharged mentally ill children over the course of 12 days in 1990 routinely 
accomplished these tasks in 4 1/2 days by 2000" (Case, et aI., 2007, p.94). It is important 
to note that alarmingly, the quartile with the longest length of stay had the greatest 
reduction in length of stay"... while the 75th percentile fell significantly from 27.2 to 7.7 
days, a decline of 72%" (Case, et aI., 2007, p.94). Case, et aI., (2007) follows with, 
Declines in average length of stay over the period were generally greatest for 
diagnoses and other characteristics associated with the longest average length of stay 
in 1990. Rather than a targeted reduction of average length of stay for treatment of 
patients with less severe illnesses and, presumably, less complex clinical needs, this 
trend in average length of stay suggests the emergence of a more uniform standard of 
inpatient treatment duration irrespective of patient need. (p.94) 
This leads to another fact of concern, "Inpatient mental health professionals routinely 
evaluate, treat, and discharge depressed children and adolescents in 4 days, well before 
the onset of response to selective serotonin reuptake inhibitor pharmacotherapy or the 
emergence of adverse effects" (Case, et aI., 2007, p.95). This not only leads to a potential 
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health risk but an issue of follow-up care. Accounting for the effects of anti-depressant 
medication and the increase in suicidal ideation at the beginning of anti-depressant 
treatment in children and adolescents, discharging them within days of beginning this 
medication is alarming without intensive follow-up to insure the safety of the patient. 
In addition, research by Case, et al. (2007) indicates that transfers to other 
inpatient facilities and subsequent treatment are on the decline, with the majority of 
discharges being to home. Considering the severity of the majority of the illnesses at 
admission this fact is disconcerting. Additionally, this particular study did not address 
readmission, as the patients were not identified as to allow such analysis, lending to an 
uncertainty about the effectiveness of the initial admission. 
Several possible conclusions could be garnered from this information. To name a 
few, first, in order to provide the care the patient needs" ...under scrutiny ofmanaged 
care review, inpatient providers may be indicating more serious diagnoses to justify 
admission or secure greater reimbursement, a process termed "diagnostic upcoding"" 
(Case, et al., 2007, p.95). Second, there is a disproportionate case mix found at 
community hospitals. Third, private hospitals and programs are not accounted for within 
this study. 
According to work done by Horvitz-Lennon, Normand, Gaccione, and Frank 
(2001), "Rising mental health spending has triggered cost-containment efforts primarily 
aimed at decreasing inpatient utilization" (p. 676). They discovered that, "Regardless of 
study design, the most frequent exclusion criterion was, by far, "too severely ill" (i.e., 
dangerousness to self or others; disruptive behavior). Other frequent exclusion criteria 
were cognitive impairment and antisocial behavior" (Horvitz-Lennon et al., 2001, p.680). 
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The determination made at the end of the study was that there was no difference in effect 
between partial hospitalization and inpatient treatments. It is important to note that this 
result cannot be generalized beyond the applicable population of this research, due to the 
large amount of exclusions and transference of care from partial to inpatient. In addition, 
Horvitz-Lennon et al., (2001) also assert" ...61% to approximately 80% of partial care 
patients will eventually be transferred and fully hospitalized. Conversely, approximately 
21% to 39% of acutely ill patients may be solely treated with partial hospitalization" 
(p.682). 
The average length of a hospital stay for a psychiatric patient can also be 
complicated by co-morbidity of medical illness. Work done by Lyketsos, Dunn, 
Kaminsky, and Breakey (2002) details the issues of comorbidity in psychiatric inpatient 
cases. According to Lyketsos, et al., (2002), "A wide range of comorbidity has been 
described, with chronic medical illnesses such as hypertension, heart disease, pulmonary 
disease, and diabetes, being the most common" (p.24). This is a concern considering 
these medical illnesses are chronic and require monitoring and in many cases medications 
in order to control. According to Lyketsos, et al., (2002) this can have effects on 
psychiatric outcomes, average length of stay, and overall patient functioning. The 
concern is that "Psychiatric medications also have health effects, such as impaired 
glucose tolerances, effects on renal function, effects on liver function, and many others" 
(Lyketsos, et al., 2002, p.24), leading to further medical complications in treatment and 
effects. In addition, Lyketsos, et al., (2002) state, "Medications used to treat medical 
illness often have psychiatric effects" (p.24), which leads also to the concern that 
medications used to treat medical illnesses are contributing to the outcomes of psychiatric 
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diagnosis and treatments, a viscous circle ofmedicating to counter the effects of the 
medications. 
Additionally, Lyketsos, et al. (2002) believe that, "another link is that psychiatric 
patients are less motivated to seek care for medical illness. They are often neglectful of 
their health and self-care" (p.24), which leads to the possibility that psychiatric patients 
are at greater risk for medication non-compliance, greater levels of morbidity, and 
mortality related to medical illness due to their psychiatric illness. A serious concern for 
doctors, mental health professionals, and insurance companies alike is the statement by 
Lyketsos, et al., (2002) that, " ... psychiatric patients are less likely to receive necessary 
medical care and have higher rates ofmorbidity and mortality from medical illnesses 
when compared with control populations" (p.25). Psychiatric patients need more attention 
and care in order to avoid the higher rates of morbidity and mortality rates. In addition, 
Lyketsos, et al. (2002) state that" ... medically ill psychiatric patients might have more 
severe psychiatric symptoms, might have greater functional impairment, and might have 
longer lengths of stay when hospitalized on psychiatric units" (p.25), due to the greater 
need for more specialized and intensive care brought on by the combination of 
psychiatric illness, side effects of a medical nature due to psychiatric medications, 
medical illness, and psychiatric side effects of medically needed medications. "The 
presence of a physical diagnosis in depressed inpatients was associated with a stay on the 
psychiatric unit of a general hospital that was on average 4 days longer" (Lyketsos, et al., 
2002, p.25), assumed to be due to the intensity of care required for complicated cases. 
Despite the longer hospital stay required by cases of a co-morbid nature at 
discharge these patients are more impaired in their functioning. According to Lyketsos, et 
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al., (2002), " ... average length of stay was significantly longer by an average of 5.4 days" 
(p.27). This is concern considering that the stay was longer yet the functioning more 
impaired upon discharge, most likely leading to another inpatient admission or further 
outpatient care upon discharge. 
Work completed by Pavkov, Boerge, and Czapkowicz (1997) address the concern 
of average length of stay related to youth hospitalizations in Illinois. The findings showed 
that, "those diagnosed with attention deficit, psychotic, and conduct disorder experienced 
longer hospitalizations, in contrast youths diagnosed with depressive disorders, drug and 
alcohol disorders, and adjustment disorders had shorter hospitalizations" (Pavkov, et al., 
1997, p.221). In their work, Pavkov, et al., (1997) point out that, "Some investigators 
have speculated that the length of hospitalization is dependent upon the type and array of 
community-based services available in different geographic locations" (p.222). 
Interestingly, the work by Grinshpoon, Shershevsky, Levinson, and Ponozovsky 
(2003) in Israel on a population of long term stay patients, of whom 70% were 
schizophrenic with an ICD-I0 diagnosis, supports the notion that residential treatment 
does in fact save inpatient hospitalization time. " ... (1) only one out of three residents was 
rehospitalized, (2) and whenever hospitalization was needed, the inpatient stay was 
substantially shorter" (Grinshpoon, et al., 2003, p.272). Unfortunately, the study did not 
assess the levels of functioning attained or not attained by the patients who were 
transferred from inpatient to residential care. The primary goal of treatment should be the 
improvement of patient functioning using the most effective means available, regardless 
of whether the means which achieve the goal are inpatient hospitalization, outpatient 
treatment options, or a combination. The study provides evidence that the 
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" ... rehospitalized residents tended to be younger at first-in-life hospitalization ... than 
their nonhospitalized counterparts ... " (p.272). 
A note ofcaution was included by Grinshpoon, et al. (2003). "However, we are 
aware that the overall cost of community care is higher than the cost of running the 
residences, because services that were provided within the hospital are now only 
available outside of the hospitals ... a more rigorous design comparing direct and indirect 
expenditures in hospital and community is required to answer this question" (p.272). This 
indication that there is a lack of overall cost benefit analysis between residential, 
community, and inpatient costs is a concern. Work would need to be completed first to 
determine which methods of treatments are most effective in terms of different diagnoses. 
Second, the costs of different methods of treatment would have to be determined. Third, 
the cost and benefit of each treatment would have to be laid out and analyzed in order to 
give a more definitive answer to the question, Should long term hospitalized patients 
remain hospitalized or should they be moved to residential or community treatment 
options? This particular research doesn't truly answer this question. It tells us that 
residential and community treatment options save inpatient hospital days. The real 
question is, at what cost does the saving of inpatient days come? 
Research completed by Kunik, Edwards, Molinari, Hale, and Orengo (2001) on 
geriatric patients specifically suffering from dementia show support for decreasing length 
of stay. Although the length of stay considered in this particular study could be construed 
as a long length of stay in general, "a length of stay beyond 20 days rather than beyond 
30 days, as previously required' (Kunik, et al., 2001, p.376) requires reporting to their 
chief. This reduction in average length of stay by 10 days did" ... indicate that the 
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cognitive and emotional status of patients discharged since that time are equivalent to 
those of patients discharged after longer hospital stays" (Kunik, et aI., 2001, p.376), 
suggesting that this reduction did not have any effect on patient outcomes. Although there 
was a possible change in outpatient services due to, "shortened lengths of stay, 
geropsychiatry outpatient services were enhanced - for example, a geropychologist was 
added to the outpatient treatment plan" (Kunik, et aI., 2001, p.377). This leaves 
unanswered the question, did outpatient services increase and at what cost? Was there an 
increase in readmissions? It would be valuable to know whether the outpatient treatment 
had to be extended, since it appears that patient outcome remained the same regardless of 
the change in average length of stay. 
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Chapter III: Methodology 
This section is a review of the methods used to complete this study. The problem 
this research addresses is whether average length of stay is at all indicative of 
readmission rate. In other words does average length ofhospital inpatient stay explain 
any variance in the rate of inpatient readmission, defined as an industry standard of 
readmission within 7 days of discharge or readmission within 30 days of discharge? The 
following section discusses the participant selection and description, instrumentation, 
data collection procedures, data analysis, and limitations ofthis study. 
Participant Selection and Description 
The population consists of all members ofthe mental health insurance company, 
and may be representative of all mental health patients throughout the country. The 
sample consisted of all claims paid by the mental health insurance company between July 
1,2003 through June 30, 2005 and between January 1,2005 through December 31,2006. 
In the first two experiments all population subgroups were combined in the final 
experiment the population subgroups were separated. 
In order to determine population subgroups first, the claim was assessed by 
determining if there was a diagnosis for eating disorders, as seen in Appendix A. If the 
claim did not have a diagnosis for eating disorders, it was examined for diagnosis codes 
for complex cases, as seen in Appendix B. Ifthe claim was not related to an eating 
disorder or complex case diagnosis, it was then tested for substance abuse and 
detoxification diagnosis codes, as seen in Appendix C. If the claim did belong to one of 
those classifications the claim was then classified as adult general mental health or child 
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general mental health based upon the age of the patient. The dates selected were based 
upon convenience as those were the dates which data was readily available to analyze. 
Instrumentation 
SAS for Windows, version 9.1.3 service pack 4, was used to complete the data 
analysis. 
Data Collection Procedures 
The sample consisted of all claims paid by the mental health insurance company 
between July 1,2003 through June 30, 2005 and between January 1, 2005 through 
December 31, 2006. This data is contained in the data warehouse within the mental health 
insurance company, the data used is based on claims paid. The data were pooled after a 
minimum of 90 days from the date of service related to the claim to ensure that a limited 
number of claims would be lost in adjudication. The data sets are limited to those 
members with an inpatient mental health stay. Access to this data is limited to authorized 
personnel working within the company which this research was completed. 
Limitations 
This study is limited to claims data alone, meaning that any inpatient admissions 
or readmissions which were not paid by the mental health insurance company were not 
included in the research. This is considered a serious limitation considering the lack of 
generalizability of the research to all inpatient stays. Readmissions which were not 
covered by the mental health insurance company are not included in the study. Those 
people who do not have access to mental health insurance from the mental health 
insurance company are not included in the study as we do not have any information 
beyond those claims which the mental health insurance company has paid. It could be 
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assumed that people who do not have access to mental health insurance will be a 
population of different demographics and socio-economical status therefore these results 
in no way should be generalized to a population of non-mental health insured individuals. 
Another limitation is the short time frame, limiting the variety of claims. Additionally, 
this study only assesses industry standard 7 day readmissions and 30 day readmissions, 
but long term affects of inpatient stays in terms of readmission would be of interest. 
Finally, this research was conducted within a single mental health insurance company. 
Summary 
The data was divided into length of stay groupings for analysis as described 
above. The groupings were based on approximate quartiles of the data. The analyses will 
consisted of fourteen, one-way ANOVAs, comparing the different length of stay 
groupings to readmission rates at 7 and 30 days. Keeping in mind the limitation that this 
research was conducted within a single mental health insurance company, the results 
should be interpreted with caution with regard to generalizability. 
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Chapter IV: Results 
The analysis began with frequencies for days paid to determine groupings for 
average length of stay. Days paid indicated that stays in length of 2 to 3 days accounted 
for 30.69% of claims and were assigned Group 1; stays in length of 4 to 5 days accounted 
for 29.02% of claims and were assigned Group 2; stays in length of 6 to 7 days accounted 
for 18.4% of claims and were assigned Group 3; and last, stays in length of 8+ days 
accounted for 21.89% of claims and were assigned to Group 4; as shown in table 1. The 
data were quartile to allow for more meaningful analysis, exact quartering was not 
possible so, approximate quartiles were used. 
Table 1 
Cumulative Percent ofDays Paidfor All Claims 
Days Paid Frequency Cumulative Percent 
12,346 12.99% 
3 16,826 30.69% 
4 15,028 46.51% 
5 12,551 59.71% 
6 9,853 70.08% 
7 7,636 78.11% 
8 4,524 82.87% 
9 3,101 86.13% 
10 2,411 88.67%
 
11 1,865 90.63%
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Days Paid Frequency 
12 1,434 
13 1,304
 
14 1,183
 
15 746 
16 583 
17 508 
18 479 
19 336 
20 314 
21 293 
22 172 
23 170 
24 151 
25 130 
26 104 
27 109 
28 109 
29 102 
30 134 
31 60 
32 39 
33 25 
Cumulative Percent
 
92.14%
 
93.51%
 
94.76%
 
95.54%
 
96.16%
 
96.69%
 
97.20% 
97.55% 
97.88% 
98.19% 
98.37% 
98.55% 
98.71% 
98.84% 
98.95% 
99.07% 
99.18% 
99.29% 
99.43% 
99.49% 
99.53% 
99.56% 
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Days Paid Frequency 
34 37 
35 40 
36 42 
37 16 
38 28 
39 11 
40 25 
41 21 
42 17 
43 14 
44 15 
45 73 
46 2 
47 4
 
48 8 
49 7 
50 12 
51 8 
52 3 
53 1 
55 4 
57 2 
Cumulative Percent 
99.60% 
99.64%
 
99.69%
 
99.70%
 
99.73%
 
99.74% 
99.77% 
99.79% 
99.81% 
99.83% 
99.84% 
99.92% 
99.92% 
99.92% 
99.93% 
99.94% 
99.95% 
99.96% 
99.96% 
99.97% 
99.97% 
99.97% 
19 
58 
Days Paid Frequency Cumulative Percent 
2 99.97% 
59 2 99.98%
 
60 3 99.98%
 
61 2 99.98% 
63 1 99.98% 
66 2 99.98% 
68 4 99.99% 
70 2 99.99% 
73 1 99.99% 
77 1 99.99% 
87 1 99.99% 
110 3 100% 
124 3 100% 
Frequency distribution information for claims data from July 1,2003 through 
June 30, 2005 revealed that 30,782 claims were for adult general mental health, 4,391 
claims were for complex cases, 10,109 claims were for child general mental health, 
10,973 claims were for substance abuse & detoxification, and 364 claims were for eating 
disorders, as indicated in table 2. Frequency distribution information for claims data from 
January 1,2005 through December 31,2006 revealed that 20,841 claims were for adult 
general mental health, 3,084 claims were for complex cases, 6,550 claims were for child 
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general mental health, 7,662 claims were for substance abuse & detoxification, and 287 
claims were for eating disorders, also indicated in table 2. 
Table 2 
Comparison ofthe Number ofClaims for Each Subpopulation Based on Claim Time 
Period 
Time Period Eating Complex Substance Adult Child 
Disorders Cases Abuse & General General 
Detoxification Mental Mental 
Health Health 
July 1, 2003 through 364 4,391 10,973 30,782 10,109 
June 30, 2005 
January 1,2005 through 287 3,084 7,662 20,841 6,550 
December 31, 2006 
Total Claims 651 7,475 18,635 51,623 16,659 
Fourteen One-Way Analyses of Variance (ANOYA) were completed. They 
included two on the claims from July 1,2003 through June 30, 2005, two on claims from 
January 1, 2005 through December 31, 2006, and ten on the combined claims of July 1, 
2003 through June, 302005 and January 1,2005 through December 31, 2006 which were 
separated by diagnosis code into population subgroups, to determine if different 
population subgroups have different needs regarding length of stay in relation to 
readmission rates. 
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The following are the results of three sets of one-way ANOVA on the inpatient 
hospital stay claims data collected at CIGNA Behavioral Health. The first two one-way 
ANOVA are completed on claims data July 1, 2003 to June 30, 2005, the second two 
one-way ANOVA are completed on claims data January 1, 2005 to December 31, 2006 in 
order to show repeatability ofthe results ofthe first two ANOVA. The third set of 
ANOVA is on the combined claims data found in the first two sets of ANOVA, separated 
out by population. This separation by population is an attempt to ascertain the effects of 
the days paid groupings on different populations. The goal of all three sets of analyses is 
to ascertain the effects of the length of inpatient stay on readmission rates at 7 days and 
30 days. 
Cohort July 1, 2003 - June 30, 2005 
The first set of one-way ANOVA was completed on data ranging July 1,2003 to 
June 30, 2005. As stated earlier, the groupings of days paid were used in the analyses to 
compare shorter lengths of stay to longer lengths of stay, to determine whether there was 
an effect on readmission rates at 7 and 30 days. The data set included 56,619 
observations. The results for readmission rates at 7 days indicate F (3, 56615) = 14.34, P 
< .01, as indicated in Table 3. Group 1 had 17,690 observations (M = .089), Group 2 
had 16,280 observations (M = .082), Group 3 had 10,199 observations (M = .086), and 
Group 4 had 12,450 observations (M = .104). Tukey's Studentized Range (HSD) was 
then completed to determine significance within specific comparisons. Significant results 
included; Group 4 to Group 1, Group 4 to Group 3, Group 4 to Group 2, and Group 1 to 
Group 3, as indicated in Table 4. 
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Table 3 
One-Way ANOVAfor Days Paid Groups and Readmission Rate at 7 Days July 1,2003 to 
June 30, 2005 
Source Df SS MS F p 
Days Paid Grouped 3 3.51 1.17 14.34 <.0001 ** 
Error 56,615 4,623.16 .082 
Corrected Total 56,618 4,626.67 
*p < .05 ** p < .01 
Table 4 
HSD Comparisons Days Paid Groups and Readmission Rate at 7 Days for July 1, 2003 
to June 30, 2005 
Days Paid Group 
Comparison 
Group 4 - Group 1 
Difference 
Between Means 
.015 
Simultaneous 95% Confidence Limits 
Lower Bound Upper Bound 
.007 .024* 
Group 4 - Group 3 .017 .008 .027* 
Group 4 - Group 2 .022 .013 .030* 
Group 1 - Group 3 .002 -.007 .011* 
Group 1 - Group 2 .006 -.002 .014 
Group 3 - Group 2 .004 -.005 .013 
*p < .05 ** p < .01 
The results for readmission rates at 30 days indicate F (3, 56615) = 31.72, p < 
.01, as indicated in Table 5. Group 1 had 17,690 observations (M= .136), Group 2 had 
16,280 observations (M=.135), Group 3 had 10,199 observations (M= .148), and Group 
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4 had 12,450 observations (M= .171). Tukey's Studentized Range (HSD) was then 
completed to determine significance within specific comparisons. Significant results 
included; Group 4 to Group 3, Group 4 to Group 1, Group 4 to Group 2, Group 3 to 
Group 1, and Group 2 to Group 3, as indicated in Table 6. 
Table 5 
One-Way ANOVAfor Days Paid Groups and Readmission Rate at 30 Days for July 1, 
2003 to June 30, 2005 
Source Df SS MS F P 
Days Paid Grouped 3 11.84 3.95 31.72 <.0001 ** 
Error 56,615 7,048.08 .12 
Corrected Total 56,618 7,059.93 
*p < .05 ** p < .01 
Table 6 
HSD Comparisons Days Paid Groups and Readmission Rate at 30 Daysfor July 1,2003 
to June 30,2005 
Days Paid Group 
Comparison 
Group 4 - Group 3 
Difference 
Between Means 
.023 
Simultaneous 95% 
Lower Bound 
.011 
.Confidence Limits 
Upper Bound 
.036* 
Group 4 - Group 1 .036 .025 .046* 
Group 4 - Group 2 .036 .025 .047* 
Group 3 - Group 4 -.023 -.036 -.011* 
Group 3 - Group 1 .012 .001 .024* 
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Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 3 - Group 2 .012 -001 .024* 
Group 1 - Group 2 .000 -.009 .010 
*p < .05 ** P < .01 
Cohort January 1,2005 to December 31,2006 
The second set of one-way ANOVA was completed on data ranging January 1, 
2005 to December 31, 2006. The groupings of days paid as stated previously in the 
methods section were used in analysis to compare shorter lengths of stay to longer 
lengths of stay to determine ifthere was an effect on readmission rates at 7 and 30 days. 
The data set included 38,424 observations. The results for readmission rates at 7 days 
indicate F (3,38420) = 10.67,p < .01, as indicated in Table 7. Group 1 had 11,482 
observations (M= .093), Group 2 had 11,299 observations (M= .087), Group 3 had 7,290 
observations (M= .097), and Group 4 had 8,353 observations (M= .110). Tukey's 
Studentized Range (HSD) was then completed to determine significance within specific 
comparisons. Significant results included; Group 4 to Group 3, Group 4 to Group 1, and 
Group 4 to Group 2, as indicated in Table 8. 
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Table 7 
One-Way ANOVAfor Days Paid Groups and Readmission Rate at 7 Days for January 1, 
2005 to December 31, 2006 
Source Df SS MS F p 
Days Paid Grouped 3 2.78 .93 10.67 <.0001 ** 
Error 38,420 3,336.09 .09 
Corrected Total 38,423 3,338.87 
* p < .05 ** P < .01 
Table 8 
HSD Comparisons Days Paid Groups and Readmission Rate at 7 Days January 1, 2005 
to December 31, 2006 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 4 - Group 3 .014 .001 .026* 
Group 4 - Group 1 .017 .007 .028* 
Group 4 - Group 2 .024 .013 .034* 
Group 3 - Group 1 .004 -.007 .015 
Group 3 - Group 2 .010 -.001 .021 
Group 1 - Group 2 .006 -.004 .016 
*P < .05 ** P < .01 
The results for readmission rates at 30 days indicate F (3, 38420) = 26.28, P< .01, 
as indicated in Table 9. Group 1 had 11,482 observations (M = .139), Group 2 had 11,299 
(M=.146), Group 3 had 7,290 observations (M= .097), and Group 4 had 8,353 
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observations (M= .110). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. Significant results included; Group 4 
to Group 3, Group 4 to Group 2, Group 4 to Group 1, Group 3 to Group 2, Group 3 to 
Group 1, and Group 1 to Group 3, as indicated in Table 10. 
Table 9 
One-Way ANOVAfor Days Paid Groups and Readmission Rate at 30 Days for January 
1, 2005 to December 31, 2006 
Source Df SS MS F p 
Days Paid Grouped 3 10.35 3.45 26.28 <.0001 ** 
Error 38,420 5,043.79 .13 
Corrected Total 38,423 5,054.14 
*P < .05 ** P < .01 
Table 10 
HSD Comparisons Days Paid Groups and Readmission Rate at 30 Days January 1,2005 
to December 31, 2006 
Days Paid Group 
Comparison 
Group 4 - Group 3 
Difference 
Between Means 
.017 
Simultaneous 95% Confidence Limits 
Lower Bound Upper Bound 
.002 .032* 
Group 4 - Group 2 .035 .022 .049* 
Group 4 - Group 1 .042 .029 .056* 
Group 3 - Group 2 .018 .004 .032* 
Group 3 - Group 1 .025 .011 .039* 
Group 2 - Group 1 .007 -.005 .019 
*p < .05 ** P < .01 
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Combined Cohorts 
The third set of one-way ANOVA was completed on the combined cohorts of 
data ranging July 1, 2003 to June 30, 2005 and January 1,2005 to December 31, 2006. 
The groupings of days paid as stated previously in the methods section were used in 
analysis to compare shorter lengths of stay to longer lengths of stay to determine if there 
was an effect on readmission rates at 7 and 30 days. The analysis was conducted by 
populations and they were divided out by Adult General Mental Health, Child General 
Mental Health, Eating Disorders, Complex Cases, and Substance Abuse & 
Detoxification. 
Adult General Mental Health 
The data set Adult General Mental Health included 51,622 observations. The 
results for readmission rates at 7 days indicate F (3,51619) = 18.83,p < .01, as indicated 
in Table 11. Group 1 had 15,587 observations (M= .087), Group 2 had 13,575 
observations (M= .087), Group 3 had 9,519 observations (M= .091), and Group 4 had 
12,942 (M = .110). Tukey's Studentized Range (HSD) was then completed to determine 
significance within specific comparisons. Significant results included; Group 4 to Group 
3, Group 4 to Group 1, and Group 4 to Group 2, as indicated in Table 12. 
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Table 11 
One-Way ANOVAfor Adult General Mental Health Population Days Paid Groups and. 
Readmission Rate at 7 Days 
Source Df SS MS F p 
Days Paid Grouped 3 4.80 1.60 18.83 <.0001 ** 
Error 51,619 4,382.23 .08 
Corrected Total 51,622 4,387.03 
* p < .05 ** p < .01 
Table 12 
HSD Comparisons Adult General Mental Health Population Days Paid Groups and 
Readmission Rate at 7 Days 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 4 - Group 3 .019 .009 .029* 
Group 4 - Group 1 .023 .014 .032* 
Group 4 - Group 2 .023 .014 .003* 
Group 3 - Group 1 .004 -.006 .013 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 3 - Group 2 .004 -.006 .014 
Group 1 - Group 2 .000 -.008 .009 
*p < .05 ** p < .01 
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The results for readmission rates at 30 days indicate F (3,51619) = 48.69,p< .01, 
as indicated in Table 13. Group 1 had 15,587 observations (M= .133), Group 2 had 
13,575 observations (M=.148), Group 3 had 9,519 observations (M= .160), and Group 4 
had 12,942 observations (M= .184). Tukey's Studentized Range (HSD) was then 
completed to determine significance within specific comparisons. Significant results 
included; Group 4 to Group 3, Group 4 to Group 2, Group 4 to Group 1, Group 3 to . 
Group 1, and Group 2 to Group 1, as indicated in Table 14. 
Table 13 
One-Way ANOVAfor Adult General Mental Health Population Days Paid Groups and 
Readmission Rate at 30 Days 
Source Df SS MS F P 
Days Paid Grouped 3 19.09 6.36 48.69 <.0001 * 
Error 51,619 6,746.67 .13 
Corrected Total 51,622 6,765.76 
*p < .05 ** p < .01 
Table 14 
HSD Comparisons Adult General Mental Health Population Days Paid Groups and 
Readmission Rate at 30 Days 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 4 - Group 3 .024 .012 .037* 
Group 4 - Group 2 .036 .025 .048*
 
Group 4 - Group 1 .051 .040 .062*
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Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 3 - Group 2 .012 -.000 .025 
Group 3 - Group 1 .027 .014 .039* 
Group 2 - Group 1 .014 .003 .025* 
*p < .05 ** P < .01 
Complex Cases 
The data set Complex Cases included 7,475 observations. The results for 
readmission rates at 7 days indicate F (3, 7471) = 3.04, P = .03, as indicated in Table 15. 
Group 1 had 1,615 observations (M= .099), Group 2 had 1,722 observations (M= .070), 
Group 3 had 1,366 observations (M= .089), and Group 4 had 2,772 observations (M= 
.090). Tukey's Studentized Range (HSD) was then completed to determine significance 
within specific comparisons. The only significant pair was between Group 1 to Group 2, 
as indicated in Table 16. 
Table 15 
One-Way ANOVAfor Complex Cases Population Days Paid Groups and Readmission 
Rate at 7 Days 
Source Df SS MS F' p 
Days Paid Grouped 3 .73 .24 3.04 .03* 
Error 7,471 597.70 .08 
Corrected Total 7,747 598.43 
*p < .05 ** p < .01 
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Table 16 
HSD Comparisons Complex Case Population Days Paid Groups and Readmission Rate 
at 7 Days 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 1 - Group 4 .008 -.015 .031 
Group 1 -Group 3 .010 -.017 .036 
Group 1 - Group 2 .028 .003 .053* 
Group 4 - Group 3 .002 -.022 .026 
Group 4 - Group 2 .020 -.002 .042 
Group 3 - Group 2 .018 -.008 .045 
* P < .05 ** p < .01 
The results for readmission rates at 30 days indicate F (3, 7471) = 1.22, p = .30, 
as indicated in Table 17. Group 1 had 1,615 observations (M= .143), Group 2 had 1,722 
observations (M=.124), Group 3 had 1,366 observations (M= .089), and Group 4 had 
2,772 observations (M= .142). Tukey's Studentized Range (HSD) was not completed for 
this population as the results ofthe one-way ANOVA are not significant. 
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Table 17 
One-Way ANOVAfor Complex Cases Population Days Paid Groups and Readmission 
Rate at 30 Days 
Source Pi ss MS F p 
Days Paid Grouped 3 .043 .14 1.22 .30 
Error 7,471 885.47 .12 
Corrected Total 7,747 885.90 
*p < .05 **p < .01 
Child General Mental Health 
The data set Child General Mental Health included 16,659 observations. The 
results for readmission rates at 7 days indicate F (3, 16655) = 15.25,p < .01, as indicated 
in Table 18. Group 1 had 4,189 observations (M= .073), Group 2 had 4,891 observations 
(M= .072), Group 3 had 3,798 observations (M= .086), and Group 4 had 3,781 
observations (M= .109). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. Significant results included; Group 4 
to Group 3, Group 4 to Group 1, and Group 4 to Group 2, as indicated in Table 19. 
Table 18 
One-Way ANOVAfor Child General Mental Health Population Days Paid Groups and 
Readmission Rate at 7 Days 
Source Df SS MS F p 
Days Paid Grouped 3 3.53 1.18 15.25 <.0001 * 
Error 16,655 1285.47 .12 
Corrected Total 16,658 1289.00 
* p < .05 ** p < .01 
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Table 19 
HSD Comparisons Child General Mental Health Population Days Paid Groups and 
Readmission Rate at 7 Days 
Days Paid Group 
Comparison 
Group 4 - Group 3 
Difference 
Between Means 
.023 
Simultaneous 95% Confidence Limits 
Lower Bound Upper Bound 
.006 .039* 
Group 4 - Group 1 .036 .020 .052* 
Group 4 - Group 2 .037 .021 .052* 
Group 3 - Group 1 .013 -.003 .029 
Group 3 - Group 2 .014 -.002 .029 
Group 1 - Group 2 .000 -.014 .016 
*p < .05 ** p < .01 
The results for readmission rates at 30 days indicate F (3, 16655) = 36.46, P< .01, 
as indicated in Table 20. Group 1 had 4,189 observations (M = .118), Group 2 had 4,891 
observations (M=- .116), Group 3 had 3,798 observations (M= .147), Group 4 had 3,781 
observations (M= .186). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. Significant results included; Group 4 
to Group 3, Group 4 to Group 1, Group 4 to Group 2, Group 3 to Group 1, and Group 3 
to Group 2, as indicated in Table 21. 
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Table 20 
One-Way ANOVAfor Child General Mental Health Population Days Paid Groups and 
Readmission Rate at 30 Days 
Source Df SS MS F P 
Days Paid Grouped 3 13.06 4.35 36.46 <.0001 * 
Error 16,655 1,988.89 .12 
Corrected Total 16,658 2,001.95 
* p < .05 ** p < .01 
Table 21 
HSD Comparisons Child General Mental Health Population Days Paid Groups and 
Readmission Rate at 30 Days 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 4 - Group 3 .039 .018 .059*
 
Group 4 - Group 1 .068 .048 .089*
 
Group 4 - Group 2 .070 .051 .089* 
Group 3 - Group 1 .029 -.009 .049* 
Group 3 - Group 2 .03] -.012 .051 * 
Group 1 - Group 2 .002 -.017 .021 
* p < .05 ** P < .01 
Substance Abuse and Detoxification 
The data set Substance Abuse and Detoxification included 18,635 observations. 
The results for readmission rates at 7 days indicate F (3, 18631) = 3.27,p < .05, as 
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indicated in Table 22. Group 1 had 7,675 observations (M= .103), Group 2 had 7,283 
observations (M = .088), Group 3 had 2,690 observations (M= .095), and Group 4 had 
987 observations (M = .087). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. The only significant result was 
between Group 1 to Group 2, as indicated in Table 23. 
Table 22 
One-Way ANOVAfor Substance Abuse and Detoxification Population Days Paid Groups 
and Readmission Rate at 7 Days 
Source Df SS MS F p 
Days Paid Grouped 3 .85 .28 3.27 .02* 
Error 18,631 1,609.94 .09 
Corrected Total 18,634 1,610.78 
*p < .05 ** p < .01 
Table 23 
HSD Comparisons Substance Abuse and Detoxification Population Days Paid Groups 
and Readmission Rate at 7 Days 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 1 - Group 3 .008 -.009 .025 
Group 1 - Group 2 .014 .002 .027* 
Group 1 - Group 4 .016 -.009 .042 
Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
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Days Paid Group Difference Simultaneous 95% Confidence Limits 
Comparison Between Means 
Lower Bound Upper Bound 
Group 3 - Group 2 -.006 -.011 .023 
Group 3 - Group 4 .008 -.020 .036 
Group 2 - Group, 4 .002 -.024 .027 
*p < .05 ** p < .01 
The results for readmission rates at 30 days indicate F (3, 18631) = 2.61,p = .05, 
as indicated in Table 24. Group 1 had 7,675 observations (M= .153), Group 2 had 7,283 
observations (M= .144), Group 3 had 2,690 observations (M= .153), and Group 4 had 
987 observations (M= .124). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. No significant results were found 
between any of the groups indicating there is no real significant difference. 
Table 24 
One-Way ANOVAfor Substance Abuse and Detoxification Population Days Paid Groups 
and Readmission Rate at 30 Days 
Source Df SS MS F p 
Days Paid Grouped 3 .99 .33 2.61 .05* 
Error 18,631 2,353.75 .13 
Corrected Total 18,634 2,354.74 
* p < .05 ** p < .01 
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Eating Disorders 
The data set Eating Disorders included 651 observations. The results for 
readmission rates at 7 days indicate F (3, 647) = .54,p = .65, as indicated in Table 25. 
Group 1 had 106 observations (M = .160), Group 2 had 108 observations (M= .166), 
Group 3 had 116 observations (M= .137), and Group 4 had 321 observations and (M= 
.124). Tukey's Studentized Range (HSD) was not completed as the results were not 
significant. 
Table 25 
One-Way ANOVAfor Eating Disorders Population Days Paid Groups and Readmission 
Rate at 7 Days 
Source Df SS MS F p 
Days Paid Grouped 3 .20 .07 .54 .65 
Error 647 78.08 .12 
Corrected Total 650 78.28 
*p < .05 **p < .01 
The results for readmission rates at 30 days indicate F (3, 647) = 2.59, p = .05, as 
indicated in Table 26. Group 1 had 106 observations (M = .179), Group 2 had 108 
observations (M= .222), Group 3 had 116 observations (M= .275), and Group 4 had 321 
observations (M= .161). Tukey's Studentized Range (HSD) was then completed to 
determine significance within specific comparisons. The only significant result was 
between Group 3 to Group 4, as indicated in Table 27. 
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Table 26 
One-Way ANOVAfor Eating Disorders Population Days Paid Groups and Readmission 
Rate at 30 Days 
Source Df SS MS F P 
Days Paid Grouped 3 1.21 .40 2.59 .05* 
Error 647 101.01 .16 
Corrected Total 650 102.22 
*p < .05 ** P < .01 
Table 27 
HSD Comparisons Eating Disorders Population Days Paid Groups and Readmission 
Rate at 30 Days 
Days Paid Group 
Comparison 
Group 3 - Group 2 
Difference 
Between Means 
.054 
Simultaneous 95% Confidence Limits 
Lower Bound Upper Bound 
-.082 .190 
Group 3 - Group 1 .097 -.040 .233 
Group 3 - Group 4 .114 .004 .224* 
Group 2 - Group 1 .043 -.096 .182 
Group 2 - Group 4 .060 -.053 .173 
Group 1 - Group 4 .017 -.097 .131 
*P < .05 ** P < .01 
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Chapter V: Discussion 
The research question, as stated in the beginning of this research report was: is 
there a difference in readmission rates based on length of stay? The results indicate yes, 
there is a difference. The shortest stay group and the longest stay group were at greater 
risk for readmission than the middle two groups. The questions remain, was the shortest 
stay group under treated? Was the longest stay group at such instability that the 
likelihood of readmission is so great that it can not be avoided? 
The results for Cohort July 1,2003 - June 30, 2005 and Cohort January 1, 2005 to 
December 31, 2006 show similar trending, indicating that the repeatability of the results 
with similar trending and results is possible, in both cases the significant pairings for 7 
day readmission rates were Group 4 to Group 1, Group 4 to Group 3, Group 4 to Group 
2, shown in Table 4 & Table 8. One explanation for this is that the longest stay group is 
just so instable that readmission can not be avoided, thus why it is significantly different 
from each of the other groups. 
Similar to the 7 day readmission rate trending, the 30 day readmission rates show 
significant differences in both cohorts between Group 4 and Group 3, Group 4 and Group 
1, Group 4 and Group 2, Group 3 and Group 1, and Group 3 and Group 2. Once again, 
the instability and illness level of the longest stay may be so great that readmission is 
simply more likely. In addition, Group 3 shows significant differences from allother 
groups, although in this case there was a difference between the two cohorts' mean rates 
for 30 day readmissions. In the cohort July 1, 2003 - June 30, 2005, Group 3 had the 
second highest mean rate. One question raised is whether this group is also suffering 
from the same problems as the longest stay group, but taking longer for the group to 
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return to inpatient hospitalization. In contrast, the cohort January 1, 2005 - December 31, 
2006, Group 3 had the lowest mean rate for 30 readmissions, thus making it the least 
likely group to be readmitted. This presents a definite contradiction between cohorts. One 
possible explanation is that outpatient follow-up is possibly better for this group during 
this time period; possibly the more ill are being pushed into the groupings either longer or 
shorter than that of Group 3. 
In the adult mental health subpopulation, readmission is likely related to a longer 
stay rather than a shorter stay, as seen in their mean readmission rate for 7 day 
readmission. This may seem contradictory but it could be explained by severity of illness. 
Those with more severe illness have a longer inpatient stay. Additionally, the 30 day 
readmission rate for adult general mental health shows a similar trending. The significant 
difference between the means involved the group with the longest length of stay or Group 
4, and the group with the shortest length of stay, or Group 1. Possible explanations could 
be that Group 1, the shortest stay group, is not getting enough inpatient hospital time to 
sufficiently stabilize the patient to allow follow-up treatment to be effective, or follow-up 
treatment methods may not be sufficiently effective. Conversely, Group 4, the longest 
stay group, is most likely severely ill, elderly, having co- morbid conditions, or a 
combination and is likely to be readmitted until new treatment options are found to better 
serve this population. 
The child general mental health subpopulation showed similar results as those of 
the adult general mental health subpopulation at 7 day readmission rates, with significant 
results falling to comparisons related to Group 4, the longer length of stay group. 
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However, for the 30 day readmission rates the child general mental population showed 
significant differences between all four groups. 
The days paid grouping as applied to the complex cases of eating disorders and 
substance abuse and detoxification was not approximately quartile, as post hoc frequency 
data show. For example, complex cases was divided into Group 1, N=1,615, (21.6%), 
Group 2, N=1,722 (23.0%), Group 3, N=1,366 (18.3%), Group 4, N=2,772 (37.1%). A 
higher proportion of observations in Group 4 could certainly have a negative impact on 
the analyses; this discrepancy may explain why the results did not show as many 
significant differences between groupings as adult general mental health or child general 
mental health subpopulations. It is interesting, however, to note the distribution of 
complex cases showing a longer length of stay in contrast to the other subpopulations. 
Contrary to complex cases, the substance abuse and detoxification subpopulation 
had higher proportions in the shorter lengths of stay groups. Post hoc analysis showed 
Group 1, N=7,675 (41.2%), Group 2, N=7,283 (39.1%), Group 3, N=2,690 (14.4%), 
Group 4, N=987 (5.3%). The higher proportions in Group 1 and 2 may have had a 
negative impact on the analyses, which may be why the results did not show as many 
significant comparisons between groupings of days paid for the particular subpopulation 
when compared to adult general mental health or child general mental health 
subpopulations. It is likely that substance abuse and detoxification treatment is largely 
done at the intensive outpatient level which would explain why the stays are shorter in 
most cases when compared to the other populations. 
Similar to complex cases and contrary to substance abuse and detoxification, the 
eating disorder subpopulation was distributed heavily into the longer stay Group 4. Post 
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hoc analysis shows Group I, N=106 (16.3%), Group 2, N=108 (16.6%), Group 3, N=116 
(17.8%), Group 4, N=321 (49.3%). The greatest distribution, at almost 50% of the 
observations in the longest stay grouping, indicates that the longer stays are necessary in 
proper treatment of eating disorders. This unequal distribution may be one cause of non­
significant comparisons in analyses, due to the insensitivity of the method used in 
grouping these observations for analysis. 
Limitations 
The study is limited to the membership of the mental health insurance company 
examined and those members who had paid claims between July 1,2003 to June 30, 2005 
and January 1,2005 to December 31, 2006. These dates were chosen as a matter of 
convenience as the data were readily available for analysis at this time. This research was 
conducted on claims data within a single mental health insurance company; therefore the 
results of this study should be interpreted with caution. 
There is limited ability to generalize the overall results of the first two sets of 
ANOVA to individual subpopulations such as complex cases, eating disorders, and 
substance abuse and detoxification. This conclusion is indicated by the third set of 
ANOVA completed on separate populations. One likely reason these limitations exist is 
that the method used to divide the observations into groupings by days paid was not 
sensitive enough to account for the individual population distribution variance. Longer 
lengths of stay are needed to treat the more severely ill such as those with eating 
disorders and complex cases. Lesser readmission rates for substance abuse and 
detoxification could be explained by the commonality of intensive outpatient treatment. 
43 
Moreover, it is not known what type of follow-up care was received by the 
inpatients after discharge. It would be interesting to see the types of follow-up care that 
patients used and the engagement rates in these follow-up care methods. This would help 
to determine at what levels they are effective at treating the conditions after discharge and 
the resulting effects on inpatient readmission. 
Conclusions 
As work with cohorts from 1988 to 1996 by Liberman, et al. (1998) suggested, 
the longer lengths of stay had higher readmission rates, as did the shorter lengths of stay. 
This finding is in agreement with what was also found in the work concluded here, with 
the longest and the shortest lengths of stay showing the most likely chances for 
readmission. This conclusion was arrived at after analysis of two cohorts of large data 
sets. This lends to the validity of the statement; that more research should be done to 
investigate how average length of stay affects readmission. 
Work done by Case, et al. (2007) suggests that cases which are more complex 
should not be targeted for reduced lengths of stay. This is in agreement with the analyses 
done on subpopulations, showing the need for longer lengths of stay to treat the more 
severely ill. The effects of various treatment methods on different subpopulations would 
be valuable to determine the best methods of treatment for various diagnosis types. 
When antidepressant prescriptions are new to patients more time should be given 
to ensure there are no issues with the patient before discharge, as suggested by Lyketsos, 
et al. (2002). This is a concern for the general mental health subpopulations of adults and 
especially children, who are most vulnerable to the effects of antidepressants when they 
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are a new prescription medication. Research should be done to determine if the length of 
time such patients spend as inpatients is sufficient given the situation. 
Recommendations 
Average length of stay is a confusing and often heated topic within the mental 
health care community. The belief that we are doing a service to our patients, members, 
or clients by limiting their length ofhospital stay in favor of outpatient or partial 
hospitalization methods of treatment is complicated, to say the least. Further research 
should be conducted to help define the cost of inpatient treatment versus outpatient 
treatment or partial hospitalization by measuring the total cost of treatment and the 
relative success of the treatment method, measured in part by readmission to the same or 
similar treatment methods. 
Further research on length of stay and readmission rates should take into account 
the different subpopulations and employ methods to test hypotheses that are sensitive to 
those subpopulations. In hindsight the methods used in this research were not sensitive 
enough to individual populations but they did lend to overall knowledge of the effects of 
length of stay on readmission rates in a large scale manner. Further scrutiny should be 
focused on the variances found within the subpopulations and why those variances exist. 
That a length of stay can vary from 2 days to 124 days seems very unusual and 
contradictory. Although each case varies in complexity, treating eating disorders should 
likely have a longer length of stay than treating an adult with generalized depression and 
no other complications. 
The exclusion of the severely ill from experiments could be detrimental to the 
results as this is the area where the most ground could possibly be gained considering that 
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the more severely ill the patient the more likely they will be readmitted. Additionally, 
work done in general mental health for adults and children should be examined more 
thoroughly to ensure that the possibility of adding a day to an inpatient stay might 
possibly reduce costs and better sever the patient rather than increasing costs without 
benefit. More research should be done on outpatient programs to examine the 
transferability of successful programs to areas in need of improvements. 
This continued research is important for the improvement of the quality of care 
provided to mental health patients and clients. It is needed to determine cost containment 
measures, create standards for care better based upon the particular needs of the patient, 
and to ensure compliance of outpatient treatment and follow-up methods post discharge. 
The quality of care is the responsibility of all those involved. It does not end with the 
attending physician. 
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Appendix A: Diagnostic Codes for Eating Disorders 
Diagnosis Code Description 
307.1 Anorexia Nervosa
 
307.5 Other / Unspecified Eating Disorder
 
307.51 Bulimia
 
307.52 PICA
 
307.53 Psychogenic Rumination
 
307.59 Other Disorders Eating
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Appendix B: Diagnostic Codes for Complex Cases 
Diagnosis Code Description 
290 SenilelPresenile Psychosis 
290.1 Presenile Dementia
 
290.11 Presenile Dementia wi Delirium
 
290.12 Presenile Dementia wi Delusional Features
 
290.13 Presenile Dementia wi Depressive Features
 
290.2 Senile Dementia wi Delusional or Depressive Features
 
290.21 Senile Dementia wi Depressive Features
 
290.3 Senile Dementia wi Delirium
 
290.4 Arteriosclerotic Dementia
 
290.41 Arteriosclerotic Dementia Delirium
 
290.42 Arteriosclerotic Dementia Delusion
 
290.43 Arteriosclerotic Dementia Depressive
 
293 Transient Organic psychosis 
293.81 Organic Delusional Syndrome
 
293.82 Organic Hallucinations Syndrome
 
293.83 Organic Affective Syndrome
 
293.84 Organic Anxiety Syndrome
 
293.89 Transient Organic Mental Other
 
293.9 Transient Organic Mental Unspecified
 
294 Other Organic Psychosis 
294.1 Dementia Conditions Class Elsewhere
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Diagnosis Code Description 
294.8 Organic Brain Syndrome Other 
294.9 Organic Brain Syndrome Unspecified 
295.1 Disorganized Schizophrenia 
295.2 Catatonic Type Schizophrenia 
295.3 Paranoid Type Schizophrenia 
295.4 Acute Schizophrenic Episode 
295.6 Residual Schizophrenia 
295.7 Schizoaffective Schizophrenia 
295.9 Unspecified Schizophrenia 
297.1 Paranoia 
297.3 Shared Paranoid Disorder 
298.8 React Psychosis Other 
298.9 Psychosis Unspecified 
299 Psychosis Origin Childhood 
299.1 299.1 Disintegrative Psychosis 
299.8 299.8 Other Early Childhood Psychosis 
302.2 Pedophilia 
302.3 Transvestism 
302.4 Exhibitionism 
302.6 Psychosexual Identity Disorder 
302.7 Psychosexual Dysfunction 
302.71 Inhibited Sexual Desire 
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Diagnosis Code Description 
302.72 Inhibited Sexual Excitement 
302.73 Inhibited Female Orgasm 
302.74 Inhibited Male Orgasm 
302.75 Premature Ejaculation 
302.76 Functional Dyspareunia 
302.79 Psychosexual Dysfunction Other 
302.81 Fetishism 
302.82 Voyeurism 
302.83 Sexual Masochism 
302.84 Sexual Sadism 
302.85 Gender Identity Disorder Adult 
302.89 Psychosexual Disorder Other 
302.9 Psychosexual Disorder Unspecified 
306.51 Psychogenic Vaginismus 
307 Special Symptoms Syndromes 
307.2 Tics 
307.21 Transient Tic Childhood 
307.22 Chronis Motor Tic Disorder 
307.23 Gilles Tourette' s Disorder 
307.3 Stereotyped Movements 
307.42 Persistent Insomnia 
307.44 Persistent Hypersomnia 
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Diagnosis Code Description 
307.46 Somnambulism! Night Terror
 
307.47 Sleep Stage Dysfunction Other
 
307.6 Enuresis
 
307.7 Encopresis
 
307.8 Psychalgia
 
307.89 Other Psychalgia
 
307.9 Special Symptom Other
 
312.3 Other Impulse Control Disorder
 
312.31 Path Gambling
 
312.32 Kleptomania
 
312.33 Pyromania
 
312.34 Intermittent Explosive Disorder
 
315 Specific Delays Development
 
315.1 Arithmetical Disorder
 
315.2 Other Learning Disorder
 
315.31 Development Language Disorder
 
315.32 Receptive Language Disorder
 
315.39 Speech I Language Disorder Other
 
315.4 Coordination Disorder
 
315.9 Development Delay Unspecified
 
316 Psychic Factor wi Other Disease 
317 Mild Mental Retardation 
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Diagnosis Code Description 
318 Other Mental Retardation 
318.1 Severe Mental Retardation
 
318.2 Profound Mental Retardation
 
319 Mental Retardation Unspecified 
327.01 Insomnia Medical Condition Class Elsewhere
 
327.02 Insomnia mental Disorder
 
327.14 Hypersomnia Medical Condition
 
327.15 Hypersomnia Mental Disorder
 
327.3 Circadian Rhythm Sleep Disorder
 
327.31 Circadian Rhythm Sleep Disorder Delayed Phase Type
 
327.35 Circadian Rhythm Sleep Disorder Jet Lag Type
 
327.36 Circadian Rhythm Sleep Disorder Shift Work Type
 
327.44 Parasom Conditions Class Elsewhere
 
327.8 Other Organic Sleep Disorders
 
332.1 Secondary Parkinsonism
 
333.1 Tremor Other
 
333.7 Symptomatic Torsion Dystonia
 
333.82 Orofacial Dyskinesia
 
333.9 Other / Unspecified Extrapyramidal Disorder
 
333.92 Neuroleptic Malignant Syndrome
 
333.99 Extrapyramidal Disorder Other
 
347 Cataplexy & Narcolepsy 
625 
625.8 
780.9 
799.9 
995.2 
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Diagnosis Code Description 
Impotence Organic Origin 607.84
 
608.89 Male Genital Symptoms
 
Female Genital Symptoms 
Female Genital Symptoms Other 
780.09 Conscious Alterat. Other
 
780.57 Sleep Apnea Unspecified
 
Other General Symptoms 
787.6 Incontinence Feces
 
Unknown Cause Morb.lMort. Other 
Adv. Eff. Med. / BioI. Bub. Unspecified 
995.52 Child Neglect
 
995.53 Child Sexual Abuse
 
995.54 Child Physical Abuse
 
995.81 Adult Physical Abuse
 
995.83 Adult Sexual Abuse
 
V15.81 Hist. Med. Non Compliance
 
V61.1O Counsel Marital Problem Unspecified
 
V61.12 Counsel Spousal Abuse Perp.,
 
V61.20 Counsel Parent Child Prob.
 
V61.21 Counsel Child Abuse Victim
 
V61.8 Family Circumstances Other
 
V61.9 Family Circumstances Unspecified
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Diagnosis Code Description 
V62.2 Occupational Circumstances Unspecified
 
V62.3 Educational Circumstance
 
V62.4 Social Maladjustment
 
V62.81 Interpersonal Problem Other,
 
V62.82 Bereavement Uncomplicated
 
V62.83 Counsel Physical/Sexual Abuse Perp.
 
V62.89 Psychological Stress Other
 
V65.2 Person Feigning Illness
 
V71.0l Observe Adult Antisocial Behavior
 
V71.02 Observe Adolescent Antisocial Behavior
 
V71.09 Observe Mental Condition Other
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Appendix C: Diagnostic Codes for Substance Abuse and Detoxification 
Diagnosis Code Description 
291 Alcohol Induced Mental Disorders 
291.0 Delirium Tremens
 
291.00 Alcohol Withdrawal Delirium
 
291.1 Alcohol Amnesic Syndrome
 
291.10 Alcohol Amnesic Disorder
 
291.2 Alcoholic Dementia Other
 
291.20 Dementia Associated with Alcoholism
 
291.3 Alcohol Hullucinosis
 
291.30 Alcohol Hullucinosis
 
291.4 Idiosyncratic Alcohol Intox.,
 
291.40 Alcohol Idiosyncratic Intoxication
 
291.5 Alcoholic Jealousy
 
291.8 Other Alcoholic Psychosis
 
291.80 Uncomplicated Alcoholic Withdrawal
 
291.81 Alcohol Withdrawal
 
291.89 Other Alcoholic Psychosis
 
291.9 Alcoholic Psychosis Unspecified
 
292 Drug Induced Mental Disorders 
292.0 Drug Withdrawal Syndrome
 
292.00 Drug Withdrawal
 
292.01 Opiod Withdrawal
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Diagnosis Code Description 
292.02 Sedative Hypnotic Withdrawal
 
292.03 Cocaine Withdrawal
 
292.04 Amphetamine Withdrawal
 
292.11 Drug Induced Paranoid State
 
292.12 Drug Hallucinosis
 
292.2 Pathologic Drug Intoxication
 
292.81 Drug Induced Delirium
 
292.82 Drug Induced Dementia
 
292.83 Drug Induced Amnesiac Syndrome
 
292.84 Drug Induced Depressive Syndrome
 
292.89 Drug Induced Mental Disorder Other
 
292.9 Drug Induced Mental Disorder Unspecified
 
292.90 Unspec. Drug Induced Mental Disorder
 
303 Alcohol Dependence Syndrome 
303.0 Acute Alcoholic Intoxication
 
303.00 Acute Alcohol Intoxication Unspecified Drinking
 
303.01 Acute Alcohol Intoxication Cont. Drinking
 
303.02 Acute Alcohol Intoxication Episodic Drinking
 
303.03 Acute Alcohol Intoxication Alcoholism Remiss.
 
303.9 Other/Unspecified Alcohol Dependence
 
303.90 Other/Unspecified Alcohol Dependence Unspecified
 
303.91 Alcohol Dep. Other Continuous
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Diagnosis Code Description 
303.92 Alcohol Dep. Other Episodic
 
303.93 Alcohol Dep. Other in Remission
 
304 Drug Dependence 
304.0 Opiate Type Dependence
 
304.00 Opiate Dependence Unspecified
 
304.01 Opiate Dependence Continuous
 
304.02 Opiate Dependence Episodic
 
304.03 Opiate Dependence Remiss.
 
304.1 Barbiturate Dependence
 
304.10 Barbiturate Dependence Unspecified
 
304.11 Barbiturate Dependence Continuous
 
304.12 Barbiturate Dependence Episodic
 
304.13 Barbiturate Remission
 
304.2 Cocaine Dependence
 
304.20 Cocaine Dependence Unspecified
 
304.21 Cocaine Dependence Continuous
 
304.22 Cocaine Dependence Episodic
 
304.23 Cocaine Dependence Remission
 
304.3 Cannabis Dependence
 
304.30 Cannabis Dependence Unspecified
 
304.31 Cannabis Dependence Continuous,
 
304.32 Cannabis Dependence Episodic
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Diagnosis Code Description 
304.33 Cannabis Dependence Remission
 
304.4 Amphetamine Dependence
 
304.40 Amphetamine Dependence Unspecified
 
304.41 Amphetamine Dependence Continuous
 
304.42 Amphetamine Dependence Episodic
 
304.43 Amphetamine Dependence Remission
 
304.5 Hallucinogen Dependence
 
304.50 Hallucinogen Dependence Unspecified
 
304.6 Other Drug Dependence
 
304.60 Drug Dependence other Unspecified
 
304.61 Drug Dependence Other Continuous
 
304.62 Drug Dependence Other Episodic
 
304.63 Drug Dependence other In Remission
 
304.7 Opiate/ Other Drug Dependence
 
304.70 Opiate/ Other Drug Dependence Unspecified
 
304.71 Opiate/ Other Drug Dependence Continuous
 
304.72 Opiate/ Other Drug Dependence Episodic
 
304.73 Opiate/ Other Drug Dependence Remission
 
304.8 Multiple Drug Dependence
 
304.80 Combination Drug Dependence Other Unspecified
 
304.81 Combination Drug Dependence Other Continuous
 
304.82 Combination Drug Dependence Other Episodic
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Diagnosis Code Description 
304.83 Combination Drug Dependence Other Remission
 
304.9 Unspecified Drug Dependence
 
304.90 Unspecified Drug Dependence Unspecified
 
304.91 Drug Dependence Unspecified Continuous
 
304.92 Drug Dependence Unspecified Episodic
 
304.93 Drug Dependence Unspecified Remission
 
305 Nondependent Abuse Drugs 
305.0 Nondependent Abuse Continuous
 
305.00 Alcohol Abuse Unspecified
 
305.01 Alcohol Abuse Continuous
 
305.02 Alcohol Abuse Episodic
 
305.03 Alcohol Abuse Remission
 
305.1 Tobacco Use Disorder
 
305.10 Nicotine Dependence
 
305.11 Tobacco Disorder Continuous
 
305.12 Tobacco Disorder Episodic
 
305.13 Tobacco Disorder Remission
 
305.2 Nondependent Cannabis Abuse
 
305.20 Cannabis Abuse Unspecified
 
305.21 Cannabis Abuse Continuous
 
305.22 Cannabis Abuse Episodic
 
305.23 Cannabis Abuse Remission
 
305.3 
305.4 
305.5 
305.6 
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Diagnosis Code Description 
Nondependent Hallucinogen Abuse Unspecified 
Hallucinogen Abuse Unspecified 305.30
 
Hallucinogen Abuse Continuous 305.31
 
Hallucinogen Abuse Episodic 305.32
 
305.33 Hallucinogen Abuse Remission
 
Nondependent Barbiturate Abuse 
305.40 Barbiturate Abuse Unspecified
 
305.41 Barbiturate Abuse Continuous
 
305.42 Barbiturate Abuse Episodic
 
305.43 Barbiturate Abuse Remission
 
Nondependent Opiate Abuse 
305.50 Opiate Abuse Unspecified
 
305.51 Opiate Abuse Continuous
 
305.52 Opiate Abuse Episodic
 
305.53 Opiate Abuse Remission
 
Nondependent Cocaine Abuse 
305.60 Cocaine Abuse Unspecified
 
305.61 Cocaine Abuse Continuous
 
305.62 Cocaine Abuse Episodic
 
Cocaine Abuse Remission 305.63
 
Nondependent Amphetamine Abuse 
305.70
 Amphetamine Abuse Unspecified 
305.7 
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Diagnosis Code Description 
305.71 Amphetamine Abuse Continuous
 
305.72 Amphetamine Abuse Episodic
 
305.73 Amphetamine Abuse Remission
 
305.8 Nondependent Antidepressant Abuse
 
305.80 Antidepressant Abuse Unspecified
 
305.82 Antidepressant Abuse Episodic
 
305.9 Other Nondependent Drug Abuse
 
305.90 Drug Abuse Unspecified
 
305.91 Drug Abuse Other Continuous
 
305.92 Drug Abuse Other Episodic
 
305.93 Drug Abuse Other Remission
 
